News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Dr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USA

Advertisement

Articles by Dr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USA

Real World insights with EYLEA 8mg

ByDr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USA
July 14th 2025
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    The Retina TL;DR: Advancing sustained VEGF suppression with EYP-1901 with Jay S. Duker, MD

    2

    Frank Holz, MD, FEBO, FARVO, highlights new treatment developments at EURETINA

    3

    Q&A: The ARCHER trial and the importance of continued GA research

    4

    Challenges Reported by Young Physicians in Managing Geographic Atrophy and How these Shape Patient Care

    5

    Q&A: What is the value of the YOURS program at EURETINA?

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us